Medical marketing news, white papers, reports, and events from PharmaLeaders. New content daily, on our website and delivered right to your inbox.
CMS looks for new ideas to promote healthcare competition In a Wall Street Journal op-ed published Tuesday evening, CMS Administrator Seema Verma said her agency will issue a “request for information” on new ideas that would redirect the innovation center responsible for creating new provider payment models. Verma said the Center for Medicare and Medicaid Innovation was a powerful tool in improving healthcare quality and ... Read More
Newest opponent to Cassidy health bill? Louisiana's governor Louisiana’s U.S. Sen. Bill Cassidy is having trouble persuading leaders in his own state to back his proposal to undo President Barack Obama’s health law. Democratic Gov. John Bel Edwards announced Tuesday he opposes the Republican senator’s legislation. Edwards says it would eliminate Louisiana’s Medicaid expansion program that provides health coverage to 430,000 people. Edwards’ opposition came ... Read More
Sudden departure of Envision's physician-staffing leader raises investors' eyebrows Management changes in Envision Healthcare’s most-important business is fueling a sell-off of the physician-staffing company’s stock. Robert Coward, a long-time company executive picked in December to lead the integration of Envision’s physician-staffing business with merger-partner Amsurg’s staffing division, is leaving to pursue other opportunities. The departure comes out of the blue, in that Envision has not signaled ... Read More
10 ways the newest ACA repeal bill is harsher than the previous GOP bill The new Senate Republican bill to repeal and replace the Affordable Care Act could reduce funding, coverage and consumer protections even more sharply than the GOP’s previous repeal bill, the Better Care Reconciliation Act. Here’s how: 1. Establishes fixed state block grants that cap federal subsidies for coverage. BCRA would have continued Obamacare’s guaranteed subsidies to qualifying ... Read More
Pediatric Gene Therapy The European approvals of Glybera® in 2012 and Strimvelis® in 2016 seem likely to be the vanguard of the therapeutic revolution heralded by the decoding of the human genome. Both of these treatments originated from academic centers of excellence and became the subjects of agreements with pharmaceutical companies (Uniqure/Chiesi and GSK, respectively) with the experience ... Read More
The Great DTC Shake-Up Patient perspectives on direct-to-consumer advertising This in-depth eyeforpharma whitepaper, which we developed with Health Perspectives Group explores the evolving role of DTC advertising with direct feedback from patient’s – including exclusive results from the recent “DTC Attitudes, Behaviours and Preferences” patient study conducted by Health Stories Project – Insights, (HSPi). Read More